Illustration of a cardiovascular researcher in a modern lab at Humanitas University, applying for RTT position under MEDS-07/B scientific sector in Italy 2025
|

Fixed-Term Researcher (RTT) Position in Cardiovascular Diseases – Humanitas University 2025

Humanitas University, a leading institution in biomedical research and medical education in Italy, has officially launched a competitive selection procedure for one fixed-term researcher position (RTT – Ricercatore a Tempo Determinato) in the scientific-disciplinary sector 06/MEDS-07 – Cardiovascular and Respiratory Diseases, with a specific focus on MEDS-07/B – Cardiovascular Diseases.

This appointment is issued under Article 24, paragraph 3, of Italian Law No. 240/2010 (the “Gelmini Reform”), which regulates fixed-term research roles aimed at strengthening research capacity in strategic scientific areas.

The call, published as Decree Rectoral No. 115 of 2025, represents a significant opportunity for early- and mid-career scientists specializing in cardiology, vascular biology, or related translational fields.


Position Overview

  • Position: Fixed-term Researcher (RTT – Type B)
  • Scientific Sector: MEDS-07/B – Malattie dell’apparato cardiovascolare (Cardiovascular Diseases)
  • Duration: 3 years (non-renewable)
  • Institution: Humanitas University, Rozzano (Milan), Italy
  • Legal Basis: Art. 24, para. 3, Law 240/2010
  • Reference Document: Official Call (Bando DR 115/2025)
  • Application Portal: PICA – CINECA

Eligibility Criteria

To be eligible, candidates must meet all of the following requirements:

  1. Academic Qualification: Hold a PhD (Dottorato di Ricerca) or an equivalent foreign degree recognized in Italy.
  2. Research Experience: Demonstrate a strong scientific curriculum focused on cardiovascular diseases, including:
    • Peer-reviewed publications in high-impact journals
    • Participation in national/international research projects
    • Experience with experimental models, clinical data, or translational methodologies relevant to cardiology
  3. Language Proficiency: Fluency in English (Italian is not mandatory but considered an asset).

Note: Candidates who have already held an RTD-A (junior researcher) or RTT position under the same scientific sector may be subject to additional eligibility checks per national regulations.


Selection Procedure

The evaluation process is rigorous and merit-based, conducted by a designated Evaluation Committee (Commissione Giudicatrice). It consists of two phases:

1. Qualification Assessment (Idoneità)

The Committee reviews candidates’:

  • CV and list of publications (with impact factor, citations, and role in authorship)
  • Research projects and grants obtained
  • Teaching and mentoring experience
  • International mobility and collaborations

Only candidates who pass this threshold proceed to the interview.

2. Public Interview (Colloquio)

Shortlisted candidates present:

  • A 15-minute seminar on their past research
  • A 5-minute proposal outlining planned research activities at Humanitas
  • Responses to questions from the Committee on scientific methodology, innovation, and alignment with Humanitas’ strategic priorities (e.g., immunometabolism, heart failure, vascular inflammation)

Final ranking is based on a composite score from documentation (70%) and interview (30%).


Key Dates (Tentative)

While the official timeline is subject to update, the typical RTT procedure at Humanitas follows this schedule:

  • Application Deadline: 01 December 2025
  • Shortlist Publication: January 2026
  • Interviews: February–March 2026
  • Appointment Start: By July 1, 2026

Candidates must apply exclusively via the PICA platform . Applications sent by email or post will not be considered.


Why Apply at Humanitas?

Humanitas University and its affiliated IRCCS Hospital are globally recognized for:

  • Translational research excellence in immunology, cardiology, and precision medicine
  • State-of-the-art core facilities (imaging, genomics, biobanking)
  • Strong industry and EU collaborations (Horizon Europe, ERC projects)
  • English-speaking, international research environment

This RTT role is not only a career milestone but also a pathway to long-term integration in one of Europe’s most dynamic biomedical ecosystems.


How to Apply – Step by Step

  1. Review the full call: Download DR 115/2025 PDF
  2. Prepare documents:
    • CV (Europass or free format)
    • Publication list (with DOI/PMID)
    • Copy of PhD diploma
    • Research statement (max 2 pages)
    • Contact details of 2 referees (optional)
  3. Submit via PICA: https://pica.cineca.it/humanitas/dr-115-2025-rtt/
  4. Monitor your email for updates from the Evaluation Committee.

Final Thoughts

This RTT position in Cardiovascular Diseases (MEDS-07/B) is a strategic opportunity to advance cutting-edge research within a world-class institution. With Italy’s renewed investment in scientific talent under the National Recovery Plan (PNRR), roles like this are pivotal for building the next generation of research leaders.Don’t miss the deadline prepare your application early and align your research vision with Humanitas’ mission of innovation and impact.

For more opportunities, visit the official Humanitas Careers page or contact us.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *